Toggle navigation
Home
Search
Services
Blog
Contact
About
Hexokinase II Transcription as Antidiabetic Drugs
Stewart, Alexander A.
Osi Pharmaceuticals, Inc., Uniondale, NY, United States
Search 47 grants from Alexander Stewart
Search grants from Osi Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Innate Regulation of CD8+ T Cell Effector Activites
High throughput NAPPA-proteoimmunomics and Vibrio cholerae vaccine development
Preventive Health Services
Effect of Dietary Protein Source on Calcium Metabolism
Molecular and Functional Analysis of Human Class II Histocompatibility Antigens
Recently added grants:
Therapeutic vulnerabilities associated with PTEN missense mutations
Regulation of autophagy in bone metastasis
Role of KDM5A in pRB-mediated differentiation
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors
Regulation and function of HOX genes in Ewing sarcoma pathogenesis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44DK049882-02
Application #
2538956
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (14))
Program Officer
Harmon, Joan T
Project Start
1995-06-15
Project End
2000-06-30
Budget Start
1997-09-30
Budget End
1999-06-30
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Osi Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Uniondale
State
NY
Country
United States
Zip Code
11553
Related projects
NIH 1999
R44 DK
Hexokinase II Transcription as Antidiabetic Drugs
Stewart, Alexandria A. / Osi Pharmaceuticals, Inc.
NIH 1997
R44 DK
Hexokinase II Transcription as Antidiabetic Drugs
Stewart, Alexander A. / Osi Pharmaceuticals, Inc.
Comments
Be the first to comment on Alexander Stewart's grant